Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jun;28(6):1165-74.
doi: 10.1038/jcbfm.2008.5. Epub 2008 Feb 13.

Brain redox imaging using blood-brain barrier-permeable nitroxide MRI contrast agent

Affiliations

Brain redox imaging using blood-brain barrier-permeable nitroxide MRI contrast agent

Fuminori Hyodo et al. J Cereb Blood Flow Metab. 2008 Jun.

Abstract

Reactive oxygen species (ROS) and compromised antioxidant defense may contribute to brain disorders such as stroke, amyotrophic lateral sclerosis, etc. Nitroxides are redox-sensitive paramagnetic contrast agents and antioxidants. The ability of a blood-brain barrier (BBB)-permeable nitroxide, methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine-1-oxyl (MC-P), as a magnetic resonance-imaging (MRI) contrast agent for brain tissue redox imaging was tested. MC-P relaxation in rodent brain was quantified by MRI using a fast Look-Locker T(1)-mapping sequence. In the cerebral cortex and thalamus, the MRI signal intensity increased up to 50% after MC-P injection, but increased only by 2.7% when a BBB-impermeable nitroxide, 3CxP (3-carboxy-2,2,5,5,5-tetramethylpyrrolidine-1-oxyl) was used. The maximum concentrations in the thalamus and cerebral cortex after MC-P injection were calculated to be 1.9+/-0.35 and 3.0+/-0.50 mmol/L, respectively. These values were consistent with the ex vivo data of brain tissue and blood concentration obtained by electron paramagnetic resonance (EPR) spectroscopy. Also, reduction rates of MC-P were significantly decreased after reperfusion following transient MCAO (middle cerebral artery occlusion), a condition associated with changes in redox status resulting from oxidative damage. These results show the use of BBB-permeable nitroxides as MRI contrast agents and antioxidants to evaluate the role of ROS in neurologic diseases.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Reversible one-electron reduction / oxidation showing the interconversion and the molecular structure of MC-P. Left structure is radical form of MC-P. Right structure is reduced form (hydroxylamine) of MC-P
Figure 2
Figure 2
MR images of MC-P phantom by SPGR and LL sequences. a) Schematics of the MC-P phantom (Left column) and T1 weighted SPGR images (middle column) and T1 maps (right column) calculated from LL sequence. The center phantom was filled with PBS. MC-P was dissolved in saline. b) MR signal intensity change of MC-P phantom as a function of concentration from 0.2 mM to 50 mM. Signal intensity change (%) was calculated based on PBS phantom intensity. c) Relaxation rate (1/T1) of MC-P as a function of concentration. MRI parameters of SPGR and LL sequence are: SPGR: TR = 75 ms, TE = 3 ms, FA = 45°, NEX = 8, Scan time = 160 s, FOV = 3.2 × 3.2 cm, reconstructed image resolution = 256 × 256, slice thickness = 2.0 mm, number of slices = 6. LL sequence The LL T1 mapping data was acquired by conventional gradient-echo with TR = 10 s, TE = 2.4 ms, FA = 20°, acquisition interval = 400 ms, number of time point = 20, and matrix size = 96 × 96.
Figure 3
Figure 3
Time-course SPGR MR images of rat head region after injection of a) MC-P (cell-permeable) and b) 3CxP (cell-impermeable). Contrast agents were injected 2 min after MR scan was started. 60 serial images were obtained in 20 min. T2-weighted spin echo images (MSME image) were obtained before SPGR scan. SPGR MR parameters were as follows: image resolution was 256 × 128, zero-filled to 256 × 256 (0.125 mm resolution), FOV was 3.2 × 3.2 cm, slice thickness was 2.0 mm and 0.2 mm gap. Number of slices was 6. Green color shows MR signal intensity increased percentage (%) from the pixel of the pre-injection image. The time courses of intensity change of c) MC-P and d) 3CxP in the ROI of cerebral cortex (red color) and thalamus (blue color) are shown. e) Intensity change of MC-P without blood flow is shown. KCl (2 mL) was injected 40 s after MC-P injection and rats died within 20 s.
Figure 4
Figure 4
Redox MR imaging of rat brain after ischemia and reperfusion (IR). a) T2 weighted MR image and T1 weighted MR image of sham and IR treated rats after MC-P injection. b) Intensity change of right hemisphere in the T1 weighted MR images after MC-P injection. C) Reduction rate of right hemisphere in sham and IR treated rats. The data was averaged four animals. Error bars are SD. * p < 0.01, The significant difference between sham and IR rats by t-test.
Figure 5
Figure 5
Dynamic T1 maps of rat head region after MC-P injection acquired by LL sequence. a) Time-course T1 maps of rat head region after MC-P injection. Multi-slice LL data were acquired every 20 s by segmented EPI with TR = 10 s, TE 6.7 ms, FA = 20°, acquisition interval = 400 ms, and number of time point = 20. Slice thickness was 1.5 mm. The changes of b) T1 and c) MC-P concentration in cerebral cortex and thalamus region were shown. The MC-P concentration was calculated from T1 using equation shown in method section. Error bar is standard deviation (± SD, number of experiment was 3). * p <0.01, The significant difference of maximum concentration of MC-P between cerebral cortex and thalamus by t-test.
Figure 6
Figure 6
The quantification of oxidized and total (oxidized + reduced) MC-P in brain tissue and blood using x-band EPR. a) The concentration change of oxidized (white bar) and total (black bar) MC-P in brain tissue (N = 4). b) Time course change of blood concentration of oxidized (Hillered et al) and total MC-P (brown). Gray color shows concentration change from the MRI same as in figure 5c. Blood was collected from eyeground using heparinized capillary (N = 6).

References

    1. Anzai K, Saito K, Takeshita K, Takahashi S, Miyazaki H, Shoji H, Lee MC, Masumizu T, Ozawa T. Assessment of ESR-CT imaging by comparison with autoradiography for the distribution of a blood-brain-barrier permeable spin probe, MC-PROXYL, to rodent brain. Magn Reson Imaging. 2003;21:765–772. - PubMed
    1. Anzai K, Ueno M, Yoshida A, Furuse M, Aung W, Nakanishi I, Moritake T, Takeshita K, Ikota N. Comparison of stable nitroxide, 3-substituted 2,2,5,5-tetramethylpyrrolidine-N-oxyls, with respect to protection from radiation, prevention of DNA damage, and distribution in mice. Free Radic Biol Med. 2006;40:1170–1178. - PubMed
    1. Chuang KH, Koretsky A. Improved neuronal tract tracing using manganese enhanced magnetic resonance imaging with fast T(1) mapping. Magn Reson Med. 2006;55:604–611. - PubMed
    1. Crawley AP, Henkelman RM. A comparison of one-shot and recovery methods in T1 imaging. Magn Reson Med. 1988;7:23–34. - PubMed
    1. Erker L, Schubert R, Yakushiji H, Barlow C, Larson D, Mitchell JB, Wynshaw-Boris A. Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressor. Hum Mol Genet. 2005;14:1699–1708. - PubMed